Kiora Pharmaceuticals(KPRX) - 2025 Q4 - Annual Results

Encinitas, California — March 25, 2026 — Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced financial results for the fourth quarter and full year ended December 31, 2025, and provided a year-end business update on its pipeline of small molecules for the treatment of retinal diseases. Key fourth-quarter, full-year 2025, and recent corporate highlights include: "Our success in 2025 was defined by transitioning from trial preparation to trial execution for our two lead progr ...